Maximize Returns with AI-Powered BMY Insights




BMY Forecast


Bearish   <—>   Bullish



80% Confidence



Bullish Case: BMY's robust R&D pipeline, promising drug approvals, and undervaluation indicate potential for stock appreciation, supported by high investor call option interest and improving market sentiment.



Bearish Case: Expiring patents, growing competition, and insider selling risk pressure revenues and sentiment. High implied volatility reflects market apprehension, signaling potential downside risks.



Potential Outcomes:
  • New drug successes boost valuation (40%)
  • Revenue declines due to patent expirations (30%)
  • Continued market stagnation (30%)



Trading Oracle: Execute a bullish debit spread by buying the BMY 06/20/2025 $60 Call and selling $65 Call. Target post-pipeline news within 3-6 months. Elevated implied volatility and positive sentiment trends enhance profit potential, providing substantial alpha with favorable risk/reward.


February 01, 2025


Bristol-Myers Squibb Forecast

BMY        Bristol-Myers Squibb

4 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance.  Video Tutorial: Trade Smarter With Helium's AI Forecasts















Become a more profitable investor with AI optimized trading strategies





×

Chat with BMY


 Ask any question about BMY!